Pliant Therapeutics (PLRX) Preferred Shares Issued (2020)
Pliant Therapeutics (PLRX) reported Preferred Shares Issued of -$19000.0 for Q2 2020, down 100.04% quarter-over-quarter from $52.0 million in Q1 2020.
Pliant Therapeutics (PLRX) Preferred Shares Issued (2020) Analysis & Trends
Pliant Therapeutics (PLRX) has 1 years of Preferred Shares Issued data on file, last reported at -$19000.0 in Q2 2020.
- Preferred Shares Issued for Q2 2020 came in at -$19000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was -$19000.0 (changed N/A YoY), and the FY2020 annual result was $52.0 million, up 8.49% from the prior year.
- Preferred Shares Issued fell to -$19000.0 in Q2 2020 per PLRX's latest filing, from $52.0 million in the prior quarter.
- Over five years, Preferred Shares Issued peaked at $52.0 million in Q1 2020 and troughed at -$19000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref. Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -19,000.00 |
| Jun 30, 2020 | -19,000.00 |
| Mar 31, 2020 | 52.04 Mn |
| Mar 31, 2020 | 52.04 Mn |